Skip to content
10-Q

Quarterly Report

MARIMED INC. MRMD

0001522767-24-000091

← back to feed
Filed
Nov 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 7, 2024 381.31M sh
Long Term Debt Q3 2024 · Sep 30, 2024 $79.41M
Short Term Investments Q3 2024 · Sep 30, 2024 $0
Short Term Investments Q3 2024 · Dec 31, 2023 $88K
Cash And Equivalents Q3 2024 · Sep 30, 2024 $9.79M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $14.65M
Current Liabilities Q3 2024 · Sep 30, 2024 $44.6M
Current Liabilities Q3 2024 · Dec 31, 2023 $30.86M
Total Liabilities Q3 2024 · Sep 30, 2024 $125.84M
Total Liabilities Q3 2024 · Dec 31, 2023 $107.21M
Current Assets Q3 2024 · Sep 30, 2024 $56.68M
Current Assets Q3 2024 · Dec 31, 2023 $51.43M
Total Assets Q3 2024 · Sep 30, 2024 $212.68M
Total Assets Q3 2024 · Dec 31, 2023 $196.12M
Shares Diluted Q3 2024 · Sep 30, 2023 373.08M sh
Shares Diluted Q3 2024 · Sep 30, 2023 359.16M sh
Capex Q3 2024 · Sep 30, 2023 $14.75M
Operating Cash Flow Q3 2024 · Sep 30, 2023 $4.68M
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.01
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.02
Eps Basic Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic Q3 2024 · Sep 30, 2023 −$0.02
Net Income Q3 2024 · Sep 30, 2023 −$4.26M
Net Income Q3 2024 · Sep 30, 2023 −$5.86M
Operating Income Q3 2024 · Sep 30, 2023 $3.29M
Operating Income Q3 2024 · Sep 30, 2023 $11.97M
Gross Profit Q3 2024 · Sep 30, 2023 $16.84M
Gross Profit Q3 2024 · Sep 30, 2023 $48.6M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $21.96M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $61.1M
Revenue Q3 2024 · Sep 30, 2023 $38.8M
Revenue Q3 2024 · Sep 30, 2023 $109.7M